07 Jan 2001

Nucleo cmp - España

Updated: 07 Jan 2001

Nucleo cmp "forte" 30 capsulas

Neuralgias (lumbago, ciática, otalgias, etc), neuritis (herpes zoster, parálisis facial, polineuritis, recuperación de hemipléjicos, poliomielíticos, etc).

Nucleo cmp Description, Presentation and Dosage

Nucleo cmp Description

Nucleo cmp Drug Class Description

Complejo b, otras asociaciones

Nucleo cmp Drug Description

CAPSULAS

Nucleo cmp Presentation

Nucleo cmp Presentation

Vía im ("Forte"):. - Adultos: 1 inyectable cada 24 h. - Niños: medio inyectable cada 24 h o 1 inyectable cada 48-72 h. Vía oral ("Normal" y "forte"):. - Adultos: 1 cápsula 3 veces al día. - Niños: 1 cápsula 2 veces al día.

Nucleo cmp Manufacturer

FERRER INTERNACIONAL

Related Learning Zones

Anti-Coagulation Video Channel

Anti-Coagulation Video Channel

The Anti-Coagulation Video Channel is regularly updated with expert videos discussing how to prevent stroke and systemic embolism in non-valvular atrial fibrillation (AF) patients and how to prevent and treat venous thromboembolism (VTE). This free resource is intended for primary care practitioners and specialists involved in the treatment and follow up care of patients with AF or VTE.

This resource has been developed in collaboration with Boehringer Ingelheim.

Type 1 Childhood Diabetes CME

Type 1 Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial wellbeing of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC).

Nucleo cmp Dosage

Nucleo cmp Precautions, Reactions and Contraindications

Nucleo cmp Special Precautions

Related Drugs - Gastroenterologia

Back to top